I wonder how long Roche 454 will still be around if Ion gets to 400bp. Also if Illumina's chemistry performs as well as it looks like it will then 200-300bp is not unreasonable, coupled to PE reads we could see Illumina at 400bp mini-contigs.
With two short-read platforms offering close to Roche 454 read-lengths but with higher numbers of reads, lower costs, and in Illumina's case the simplicity of sample prep, when will we stop using 454?
With two short-read platforms offering close to Roche 454 read-lengths but with higher numbers of reads, lower costs, and in Illumina's case the simplicity of sample prep, when will we stop using 454?
Comment